$2.8MRound, 13 January 2026
Funds US expansion, new neuroscience, ophthalmology and cardiovascular models, and scaled cell manufacturing.
- Amount
- $2.8M
- Announced
- 13 January 2026
- Lead
- BroadOak Capital Partners
- Other investors
- Roslin Foundation
- Use of funds
- Funds US expansion, new neuroscience, ophthalmology and cardiovascular models, and scaled cell manufacturing.
- Checked
- Announced by the company
- Sources
- Axol Bioscience: $2.8 Million Raised To Accelerate US Expansion And Scale iPSC Cell Manufacturing businesswire.com
Axol Bioscience: $2.8 Million Raised To Accelerate US Expansion And Scale iPSC Cell Manufacturing pulse2.com